Sarah Spencer
Investor Relations Contact at VOR BIOPHARMA INC.
Profile
Sarah Spencer is currently the Head-Investor & Media at Vor Biopharma, Inc. She previously worked as a Media Relations Contact at GSK Plc and as the Vice President-Corporate Communications at Astellas Gene Therapies, Inc. from 2019 to 2021.
Ms. Spencer obtained an undergraduate degree from the State University of New York at Buffalo.
Sarah Spencer active positions
| Companies | Position | Start |
|---|---|---|
| VOR BIOPHARMA INC. | Investor Relations Contact | - |
Former positions of Sarah Spencer
| Companies | Position | End |
|---|---|---|
| AUDENTES THERAPEUTICS, INC. | Public Communications Contact | 31/03/2021 |
| GSK PLC | Public Communications Contact | - |
Training of Sarah Spencer
| State University of New York at Buffalo | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| GSK PLC | Health Technology |
| VOR BIOPHARMA INC. | Health Technology |
| Private companies | 1 |
|---|---|
Astellas Gene Therapies, Inc.
 Astellas Gene Therapies, Inc. BiotechnologyHealth Technology Astellas Gene Therapies, Inc. is a biotechnology company, which engages in the development and commercialization of gene therapy products for patients with serious and rare diseases caused by single gene defects. The company was founded by Matthew R. Patterson and Thomas J. Schuetz on November 13, 2012 and is headquartered in San Francisco, CA. | Health Technology |
- Stock Market
- Insiders
- Sarah Spencer
